Literature DB >> 11230297

Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.

H Gavras1, H R Brunner.   

Abstract

This is a personal historical account relating the events that led to the first application of angiotensin inhibition (either by ACE inhibitors or by angiotensin receptor blockade) to the investigation of the pathogenesis and treatment of hypertension, ischemic heart disease, and heart failure. Included are animal experiments, clinical observations, and the earliest clinical experimental studies that helped define some of the detrimental effects of angiotensin II and the beneficial hemodynamic results of its inhibition, which have been subsequently corroborated and amplified by large randomized outcome trials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230297     DOI: 10.1161/01.hyp.37.2.342

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  How ACE inhibitors transformed the renin-angiotensin system.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

Review 2.  Peptidomimetic therapeutics: scientific approaches and opportunities.

Authors:  Nir Qvit; Samuel J S Rubin; Travis J Urban; Daria Mochly-Rosen; Eric R Gross
Journal:  Drug Discov Today       Date:  2016-11-14       Impact factor: 7.851

Review 3.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 4.  Pleiotropic effects of inhibitors of the RAAS in the diabetic population: above and beyond blood pressure lowering.

Authors:  Haisam Ismail; Rena Mitchell; Samy I McFarlane; Amgad N Makaryus
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

5.  Arterial structural changes in rats immunized by AT1-receptor peptide.

Authors:  Bin Wang; Yu-Hua Liao; Zihua Zhou; Liudong Li; Fen Wei; Ming Wang; Yumiao Wei
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

6.  Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.

Authors:  Christina J Mackins; Seiichiro Kano; Nahid Seyedi; Ulrich Schäfer; Alicia C Reid; Takuji Machida; Randi B Silver; Roberto Levi
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.

Authors:  Saad Ahmad; Francesca Cesana; Edward Lamperti; Haralambos Gavras; Jun Yu
Journal:  Am J Hypertens       Date:  2009-09-24       Impact factor: 2.689

8.  Blockade of Central Angiotensin II AT1 Receptor Protects the Brain from Ischemia/Reperfusion Injury in Normotensive Rats.

Authors:  Hamdolah Panahpour; Ali Akbar Nekooeian; Gholam Abbas Dehghani
Journal:  Iran J Med Sci       Date:  2014-11

Review 9.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.

Authors:  Darren Shu Jeng Ting; Roger W Beuerman; Harminder S Dua; Rajamani Lakshminarayanan; Imran Mohammed
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.